// App-Quantinova.ai

410 : Correlation of Carotid Intima Media Thickness With Interleukin-6, Tumor Necrosis Factor-? and Anti-Cyclic Citrullinated Peptides In Rheumatoid Arthritis

Researchers

Presenter

  • Lourdes Nunez Atahualpa

Principal Investigators

  • Mauricio Figuroa Sanchez

  • Daniel Alberto Rocha Munoz

  • Veronica Gonzalez Diaz

  • Jorge Aguilar Arreola

  • Ana Guisllaine Bernard Medina

  • ra Nunez Atahualpa

  • Raul Vargas Ramirez

  • Beatriz Teresita Martin Marquez

  • Jorge Ivan Gamez Nava

  • Laura Gonzalez Lopez

  • Erika Martinez Garcia

  • Esther Sanchez Corona

  • Marcelo Petri

  • Rosa Navarro Hern

Medical Centers

  • Universidad de Guadalajara, Guadalajara, Mexico

  • Unidad de Investigacion en Epidemiologia Clinica del Hospital de Especialidades Centro Medico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico

  • Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico

  • Reumatologia, Antiguo Hospital Civil de Guadalajara - Fray Antonio Alcalde, Guadalajara, Mexico

  • Instituto de Investigacion en Reumatologia y del Sistema Musculo Esqueletico, Universidad de Guadalajara, Guadalajara, Mexico

  • CUCS, Universidad de Guadalajara, Instituto de Investigacion en Reumatologia y del Sistema Musculo Esqueletico,, Guadalajara, Mexico

  • Unidad de Investigacion en Epidemiologia Clinica del Hospital de Especialidades Centro Medico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico

  • Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico

  • Departamento de Medicina Interna/Rheumatologia, Hospital General Regional , Instituto Mexicano del Seguro Social IMSS, Guadalajara, Jalisco, Mexico

Locations

  • Mexico

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Rheumatoid arthritis

  • Diabetes

  • Renal insufficiency

  • Dyslipidemia

  • Hypertension

  • Inflammatory Arthritis

Biomarkers

  • anti-CCP antibodies

  • Estrogen receptor alpha

  • High sensitivity C-reactive protein

  • Interleukin 6

  • Tumor necrosis factor

  • Albumin/creatinine

Drug/Treatment

  • ILS-969

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim